Human leukocyte elastase counteracts matrix metalloproteinase-7 induced apoptosis resistance of tumor cells

Cancer Lett. 2008 Sep 18;268(2):331-9. doi: 10.1016/j.canlet.2008.04.006. Epub 2008 May 16.

Abstract

Matrix metalloproteinase-7 (MMP-7/Matrilysin) is a component of the tumor microenvironment associated with malignant progression. Its expression in tumors protects tumor cells from CD95-mediated apoptosis and the cytotoxic activity of tumor specific CD8(+) T cells. In the present study, we show that human leukocyte elastase (HLE) secreted by polymorphonuclear leukocytes cleaves MMP-7 resulting in loss of enzymatic activity. The anti-apoptotic effect of MMP-7 is reduced in the presence of HLE for CD95-, doxorubicin- and CTL-mediated apoptosis. Our data indicates that HLE may be a natural inactivator of MMP-7 which can counteract MMP-7-induced apoptosis resistance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis*
  • Cells, Cultured
  • Doxorubicin / pharmacology
  • Humans
  • Leukocyte Elastase / physiology*
  • Matrix Metalloproteinase 7 / physiology*
  • Neoplasms / pathology*
  • Neutrophils / physiology
  • T-Lymphocytes, Cytotoxic / immunology

Substances

  • Doxorubicin
  • Leukocyte Elastase
  • Matrix Metalloproteinase 7